Johnson & Johnson: One Penny, Per Hour, Forever:
Johnson & Johnson is a powerhouse with an amazing quality rating and very long, and successful track record ...
seekingalpha.com/article/4662918-johnson-and-johnson-one-penny-per-hour-forever
Paid articlePaywallStory Details
| Last Updated | |
| Total Articles | 2 |
Main Topics
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
News on this topic
Johnson & Johnson Remains A Safe Bet Amidst Talc Lawsuits And Ambrx Acquisition: Johnson & Johnson's moderate returns seem relatively safe, even taking the ...
seekingalpha.com/article/4662892-johnson-johnson-stock-remains-safe-bet-amidst-talc-lawsuits-ambrx-acquisition
Paid articlePaywallSimilar to This
Previous
Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into Earnings: Johnson & Johnson stock is Monday's IBD Stock Of The Day. The medical bellwether ...
investors.com/research/ibd-stock-of-the-day/johnson-johnson-stock-q2-2026-earnings-due/
J&J beats lawsuit alleging that talc caused three women's cancer: A Los Angeles jury on Friday sided with Johnson & Johnson in a lawsuit by the families of ...
reuters.com/legal/litigation/jj-beats-lawsuit-alleging-that-talc-caused-three-womens-cancer-2026-06-05/
One person dying every three days 'because of talc baby powder' court told: They say that talc in the baby powder was contaminated with asbestos
examinerlive.co.uk/news/uk-world-news/one-person-dying-every-three-33858680
Aberdeen woman claims Johnson & Johnson talcum powder caused cancer in group legal action
eu1.hubs.ly/H0sP_mB0
Johnson & Johnson ordered to pay $40m to women who said talc to blame for cancer: California jury finds company knew its talc-based products were dangerous but ...
theguardian.com/us-news/2025/dec/12/johnson-johnson-talc-baby-powder
Johnson & Johnson faces UK lawsuit from thousands over cancer-causing material in baby powder
financialexpress.com/life/health/johnson-amp-johnson-faces-uk-lawsuit-from-thousands-over-cancer-causing-material-in-baby-powder/4014617/
J&J shares tumble as judge rejects $10 billion talc settlement: Shares of Johnson & Johnson fell more than 5% on Tuesday after a U.S. bankruptcy judge rejected ...
reuters.com/business/healthcare-pharmaceuticals/jj-shares-fall-after-judge-rejects-10-billion-talc-settlement-2025-04-01/
How To Build A $25,000 Dividend Portfolio, Johnson & Johnson As Your Core Holding
seekingalpha.com/article/4740818-how-to-build-25000-dividend-portfolio-johnson-and-johnson-as-core-holding
Paid articlePaywall 3 Dividend Kings So You Can Sleep Well At Night: Discover why Dividend Kings like Coca-Cola, Johnson & Johnson, and Walmart are top long-term investments for ...
seekingalpha.com/article/4739580-3-dividend-kings-so-you-can-sleep-well-at-night
Paid articlePaywall Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive: Johnson & Johnson faces uncertainty with speculation about RFK Jr. at HHS ...
seekingalpha.com/article/4738675-johnson-and-johnson-policy-uncertainty-elevated-but-shares-remain-inexpensive
Paid articlePaywall
Johnson & Johnson must pay $15 million to Connecticut man who says its talc gave him cancer, jury finds
deccanherald.com/business/companies/johnson-johnson-must-pay-15-million-to-connecticut-man-who-says-its-talc-gave-him-cancer-jury-finds-3233913
Johnson & Johnson: The Dividend King Is Back: Johnson & Johnson is regaining momentum with strong growth in its innovative segments, making it an attractive ...
seekingalpha.com/article/4716746-johnson-and-johnson-the-dividend-king-is-back
Paid articlePaywall Weekly Market Pulse: Is That Goldilocks I See?: The stock market selloff at the end of the last week reduced the gains in value and smaller stocks somewhat ...
seekingalpha.com/article/4705455-weekly-market-pulse-is-that-goldilocks-i-see
Paid articlePaywall Banner Corporation 2024 Q2 - Results - Earnings Call Presentation: The following slide deck was published by Banner Corporation in conjunction with their 2024 Q2 ...
seekingalpha.com/article/4704828-banner-corporation-2024-q2-results-earnings-call-presentation
Paid articlePaywall Johnson & Johnson: A Lot Of Moving Parts, But Perhaps Finally Lurching In The Right Direction
seekingalpha.com/article/4702267-johnson-and-johnson-a-lot-of-moving-parts-but-perhaps-finally-lurching-in-the-right-direction
Paid articlePaywall Two High Conviction Dividend Buys For This Upside-Down Market: FOMO is driving stock market decisions, and investing in discounted dividend stocks may be a ...
seekingalpha.com/article/4700420-two-high-conviction-dividend-buys-for-this-upside-down-market
Paid articlePaywall Johnson & Johnson: Market Will Regret The Overreaction: Johnson & Johnson stock prices have been consistently declining in the recent 1~2 years ...
seekingalpha.com/article/4696746-johnson-and-johnson-market-will-regret-the-overreaction
Paid articlePaywall Johnson & Johnson: Buy This Bargain Before It's Gone: Johnson & Johnson exceeds expectations with strong financial results and impressive sales growth ...
seekingalpha.com/article/4684406-johnson-johnson-earnings-buy-this-bargain-before-it-is-gone
Paid articlePaywall Johnson & Johnson: Doubling Down On This 2024 Dog Of The Dow: Johnson & Johnson (JNJ) is poised for growth with solid financials, a consistent dividend streak ...
seekingalpha.com/article/4683388-johnson-and-johnson-doubling-down-on-this-2024-dog-of-the-dow-jnj-stock
Paid articlePaywall Johnson & Johnson: Positioned To Receive Benefits Of Heavy R&D Investments: Johnson & Johnson is well positioned to take advantage and keep a step ahead of its ...
seekingalpha.com/article/4665579-johnson-and-johnson-positioned-receive-benefits-heavy-r-and-d-investments
Paid articlePaywall Next